Sydney Jennings

Medical director of the NFID William Schaffner, MD, shares 3 things about the RSV vaccine that should be top of mind for primary care clinicians.

Your daily dose of clinical news you may have missed.

Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.

Your daily dose of clinical news you may have missed.

In a new study of adults with T2D and/or HF, those with higher prescription copayments were less likely to achieve 1-year adherence to GLP1-RA and SGLT2i therapies.

After an acute myocardial infarction, adults with diabetes were over 50% more likely to die after 1 year than those without diabetes, a new study shows.

Your daily dose of clinical news you may have missed.

Researchers found a total of 12 symptoms that contributed to the long COVID scoring system.

Delivering 3 vaccines to older adults is going to be a challenge this fall, says Dr William Schaffner.

Your daily dose of clinical news you may have missed.

The FDA approved Paxlovid™ for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe disease.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Findings highlight the need to develop strategies to improve weight management in primary care, according to study authors.

Brixadi is the first and only long-acting buprenorphine injectable that is available in both weekly and monthly doses.

Your daily dose of clinical news you may have missed.

Medical director of the NFID William Schaffner, MD, discusses the research behind the FDA's decision to approve the first-ever RSV vaccine.

Your daily dose of clinical news you may have missed.

A nationally recognized obesity expert discusses mental health in women with obesity.

Your daily dose of clinical news you may have missed.

Findings also showed that between 1990 and 2019, the global number of ischemic stroke deaths rose from 2 million to 3 million.

Your daily dose of clinical news you may have missed.

In a new guideline, the WHO recommends against the use of nonsugar sweeteners to control body weight or reduce the risk of noncommunicable diseases.

Your daily dose of clinical news you may have missed.

AACE 2023. Deaths among persons with diabetes in the US related to vascular complications increased from 2001 to 2020, primarily driven by renal complications.

Your daily dose of clinical news you may have missed.

Fezolinetant is the first NK3 receptor antagonist approved by the FDA for treatment of moderate-to-severe vasomotor symptoms due to menopause.

Results showed that 37% of adults feel more anxious now than they did 1 year ago.

Which state has the highest percentage of teenage drug users? Or the fewest opioid prescriptions? Answers from a new report, here.

Find out where drug abuse is most pronounced and which states are at greatest risk for associated problems, here.